Neogenomics Inc (NEO)

CapEx to Revenue

4.08%

Quarterly · Period ending:

NEO logo

NEO CapEx to Revenue

Latest reported4.08%
NEO Quarterly CapEx/Revenue (0.00% → 4.08%)
High-resolution chart · PNG

NEO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.0758%
2.6785%
4.1389%
4.4271%
3.487%
2.678%
6.7436%
6.4347%
7.9501%
3.5746%
4.5367%
2.8127%
5.1008%
7.2344%
3.2688%
6.0909%
8.2305%
7.0147%
9.5338%
12.343%
17.5372%
13.7026%
9.1312%
6.2634%
5.7785%
4.4403%
5.6855%
6.9895%
3.383%
3.3439%
4.2092%
3.1087%
6.3133%
7.357%
5.1968%
3.6525%
7.8007%
4.8755%
3.6502%
3.1319%
3.8398%
1.6766%
1.9539%
1.9979%
1.387%
3.6567%
4.212%
3.2433%
5.2395%
4.8565%
2.8653%
5.2002%
2.3649%
1.5265%
2.3634%
8.8016%
4.7146%
8.6675%
4.3357%
1.8816%
0.516%
0.8064%
1.1765%
3.5944%
4.5465%
1.3542%
6.8157%
4.0117%
1.7906%
0.0851%
2.2223%
3.9488%
2.984%
0.6033%
2.8827%
5.9393%
8.3979%
1.0886%
20.0829%
32.0884%
8.5969%
6.455%
4.657%
1.2427%
18.5579%
5.0845%
52.613%
0.8502%
0%
7.5125%
25.067%
15.9408%
8.2182%
12.2176%
138.5803%
727.762%
147.5837%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.